Press releases

19 Dec 2019 12:12
Notice of change in share capital

Milan, 19th December 2019 – Banca Farmafactoring S.p.A. communicates the new composition of its share capital (fully subscribed and paid-in), following the partial execution occurred over the period between 19th November 2019 and 3rd December 2019:

  • of the share capital increase without payment, resolved by the Board of Directors held on 8th April 2019, under the mandate granted, pursuant to art. 2443 of the Italian Civil Code, by the Extraordinary Shareholders' Meeting on 28th March 2019, for an amount equal to Euro 1,885.73 (“Delegated Share Capital Increase Without Payment”);
  • of the share capital increase with payment, resolved by the Extraordinary Shareholders' Meeting held on 28th March 2019, with the exclusion of the option right pursuant to art. 2441, fifth and sixth paragraph, of the Italian Civil Code, for an amount equal to Euro 50,050 (“Share Capital Increase With Payment”).

The certificate of the change in share capital was filed with the Milano Monza Brianza Lodi Companies Registration List on 18th December 2019.

 

TABLE 1

Current share capital

Previous share capital

 

Euro

N° of shares

Unitary

nom. value

Euro

N° of shares

Unitary

nom. value

Total of which:

131,326,409.06

170,553,778

Without nom. value

131,274,473.33

170,486,329

Without nom. value

Ordinary shares

(regular entitlement: 01/01/2019)

Current coupon number: 3

131,326,409.06

170,553,778

Without nom. value

131,274,473.33

170,486,329

Without nom. value

 

***

Additionally, in the same period stated above (between 19th November 2019 and 3rd December 2019), due to the execution of the above-mentioned Delegated Share Capital Increase Without Payment and Share Capital Increase With Payment, the share capital increased by a total amount of Euro 51,935.73 through the issue of 67,449 total new BFF ordinary shares, assigned to BFF Group’s employees in relation to the “Stock Option Plan of Banca Farmafactoring Banking Group”, originally approved by the Shareholders’ Meeting on 5th December 2016 and modified by the Shareholders' Meeting on 28th March 2019 (“Stock Option Plan”).

More specifically, with reference to the Stock Option Plan, from the beginning of the exercise period (8th April 2019) until 3rd December 2019, 266,936 shares were assigned, against 921,046 options exercised on a cash-less basis and 182.960 options exercised with the ordinary method over the same period. As a result of these exercises, the number of options assigned and not yet exercised to date amounts to 7,457,574, of which 1,359,896 are vested and exercisable options.